Shares

29 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2024

May 15, 2024

SELL
$0.73 - $2.73 $40,069 - $149,849
-54,890 Reduced 57.61%
40,394 $94,000
Q4 2023

Feb 14, 2024

BUY
$0.38 - $0.91 $36,207 - $86,708
95,284 New
95,284 $84,000
Q2 2023

Aug 14, 2023

SELL
$2.49 - $20.59 $57,401 - $474,661
-23,053 Reduced 29.77%
54,381 $146,000
Q1 2023

May 15, 2023

BUY
$15.95 - $25.18 $146,867 - $231,857
9,208 Added 13.5%
77,434 $1.44 Million
Q4 2022

Feb 13, 2023

BUY
$13.27 - $17.73 $185,992 - $248,503
14,016 Added 25.86%
68,226 $1.09 Million
Q3 2022

Nov 14, 2022

SELL
$11.4 - $14.6 $624,697 - $800,050
-54,798 Reduced 50.27%
54,210 $705,000
Q2 2022

Aug 11, 2022

BUY
$7.94 - $12.96 $294,796 - $481,178
37,128 Added 51.65%
109,008 $1.15 Million
Q1 2022

May 13, 2022

SELL
$12.02 - $16.79 $28,667 - $40,044
-2,385 Reduced 3.21%
71,880 $864,000
Q4 2021

Feb 11, 2022

BUY
$9.93 - $15.39 $30,356 - $47,047
3,057 Added 4.29%
74,265 $1.05 Million
Q3 2021

Nov 04, 2021

BUY
$10.18 - $26.64 $77,612 - $203,103
7,624 Added 11.99%
71,208 $728,000
Q2 2021

Aug 11, 2021

SELL
$18.57 - $35.68 $3.43 Million - $6.58 Million
-184,528 Reduced 74.37%
63,584 $1.69 Million
Q1 2021

May 13, 2021

SELL
$31.0 - $55.72 $499,968 - $898,652
-16,128 Reduced 6.1%
248,112 $8.61 Million
Q4 2020

Feb 16, 2021

SELL
$37.09 - $48.97 $2.71 Million - $3.58 Million
-73,129 Reduced 21.68%
264,240 $9.8 Million
Q3 2020

Nov 12, 2020

SELL
$40.47 - $45.5 $4.35 Million - $4.89 Million
-107,413 Reduced 24.15%
337,369 $13.9 Million
Q2 2020

Aug 13, 2020

BUY
$32.57 - $42.83 $9.33 Million - $12.3 Million
286,365 Added 180.77%
444,782 $18 Million
Q1 2020

May 14, 2020

BUY
$23.3 - $45.96 $30,686 - $60,529
1,317 Added 0.84%
158,417 $5.51 Million
Q4 2019

Feb 14, 2020

BUY
$34.58 - $48.06 $424,780 - $590,369
12,284 Added 8.48%
157,100 $6.74 Million
Q3 2019

Nov 14, 2019

SELL
$36.98 - $48.45 $3.04 Million - $3.98 Million
-82,133 Reduced 36.19%
144,816 $5.35 Million
Q2 2019

Aug 14, 2019

SELL
$35.13 - $55.53 $1.78 Million - $2.81 Million
-50,626 Reduced 18.24%
226,949 $10.3 Million
Q1 2019

May 15, 2019

BUY
$42.83 - $59.91 $2.32 Million - $3.25 Million
54,211 Added 24.27%
277,575 $15.1 Million
Q4 2018

Feb 14, 2019

SELL
$37.97 - $60.16 $12 Million - $19.1 Million
-317,216 Reduced 58.68%
223,364 $10.3 Million
Q3 2018

Dec 21, 2021

BUY
$56.3 - $67.25 $5.62 Million - $6.72 Million
99,854 Added 22.66%
540,580 $32.8 Million
Q3 2018

Nov 14, 2018

BUY
$56.3 - $67.25 $1.31 Million - $1.56 Million
23,224 Added 5.56%
440,726 $26.8 Million
Q2 2018

Apr 21, 2020

BUY
$44.9 - $64.95 $1.77 Million - $2.56 Million
39,344 Added 10.4%
417,502 $26.1 Million
Q2 2018

Aug 14, 2018

SELL
$44.9 - $64.95 $5.21 Million - $7.54 Million
-116,133 Reduced 23.49%
378,158 $23.7 Million
Q1 2018

Oct 18, 2019

BUY
$45.35 - $61.65 $4.97 Million - $6.76 Million
109,648 Added 28.51%
494,291 $22.8 Million
Q1 2018

May 15, 2018

BUY
$45.35 - $61.65 $502,840 - $683,575
11,088 Added 2.97%
384,643 $17.8 Million
Q4 2017

Feb 14, 2018

BUY
$41.95 - $60.1 $7.3 Million - $10.5 Million
174,126 Added 87.31%
373,555 $17.7 Million
Q3 2017

Nov 14, 2017

BUY
$33.4 - $53.9 $6.66 Million - $10.7 Million
199,429
199,429 $10.7 Million

Others Institutions Holding FGEN

About FIBROGEN INC


  • Ticker FGEN
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 93,741,200
  • Market Cap $31.9M
  • Description
  • FibroGen, Inc., a biopharmaceutical company, discovers, develops, and commercializes therapeutics to treat serious unmet medical needs. The company is developing Roxadustat, an oral small molecule inhibitor of hypoxia inducible factor prolyl hydroxylases, which has completed Phase III clinical development for the treatment of anemia in chronic k...
More about FGEN
Track This Portfolio

Track Deutsche Bank Ag\ Portfolio

Follow Deutsche Bank Ag\ and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Deutsche Bank Ag\, based on Form 13F filings with the SEC.

News

Stay updated on Deutsche Bank Ag\ with notifications on news.